PRECISION BIOSCIENCES INC (DTIL) › Operating Cash FlowPRECISION BIOSCIENCES INC (DTIL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2018: -$51.72M2019: -$71.02M2020: -$87.39M2021: -$10.85M2022: -$45.75M2023: -$84.11M2024: -$58.45M2025: -$65.84M-$65.84M2018Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$65.84M-12.7%2024-$58.45M+30.5%2023-$84.11M-83.8%2022-$45.75M-321.6%2021-$10.85M+87.6%2020-$87.39M-23.1%2019-$71.02M-37.3%2018-$51.72M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share